The CRUK Convergence Science Centre is a partnership between Imperial College London and The Institute of Cancer Research (ICR). We bring together researchers across these institutions from different disciplines to develop innovative ways to address challenges in cancer research and improve patient outcomes.
Better Research Together: Why PPIE Matters in Cancer Research
When we work together through PPIE (Patient and Public Involvement and Engagement), cancer research becomes more relevant, inclusive, and impactful from Discovery to Clinical Research. Here we explore why PPIE matters, even in early-stage discovery research, the benefits for researchers and resources to help researchers get started.
FRAME Trial Reveals Breakthrough Ovarian Cancer Treatment Leading to FDA Approval
New publication in Nature Medicine presents results from phase 1 FRAME trial – a promising new drug combination for ovarian cancer that led to accelerated FDA approval.
Small fragments, big impact: Discovering the 'Shearosomes' that drive cancer's spread
A collaborative study published in Advanced Science, involving researchers across several institutions and a Centre-funded PhD student, using critical resources provided by the CRUK Microfabrication and Prototyping facility, has revealed a previously unrecognised behaviour of circulating tumour cells that could reshape our understanding of how cancer spreads.
